Is this you? Create Your Porfile

Srdan Verstovsek

University of Massachusetts Medical School

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Srdan Verstovsek is active.

Explore More

Publication

Featured researches published by Srdan Verstovsek.

Blood | 2006

Lenalidomide therapy in myelofibrosis with myeloid metaplasia

Ayalew Tefferi; Jorge Cortes; Srdan Verstovsek; Ruben A. Mesa; Deborah A. Thomas; Terra L. Lasho; William J. Hogan; Mark R. Litzow; Jacob B. Allred; Dan Jones; Catriona Byrne; Jerome B. Zeldis; Rhett P. Ketterling; Rebecca F. McClure; Francis J. Giles; Hagop M. Kantarjian

Archive | 2003

Pharmaceutical combinations and methods for the treatment of leukemia

Francis J. Giles; Srdan Verstovsek

Novel Insights into Myelofibrosis Pathophysiology and Treatment | 2015

What we can do about anemia in myelofibrosis

Srdan Verstovsek; Francisco Cervantes; Arturo Pereira

Novel Insights into Myelofibrosis Pathophysiology and Treatment | 2015

Prognostication in myelofibrosis

Srdan Verstovsek; Francesco Passamonti; Domenica Caramazza; Barbara Mora; Margherita Maffioli

Archive | 2015

Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosi s

Koji Sasaki; Kate J. Newberry; Patrick Kelly; Hagop M. Kantarjian; Srdan Verstovsek

Archive | 2014

unclassifiable myelodysplastic/myeloproliferative neoplasms Atypical chronic myeloid leukemia is clinically distinct from

Kathryn Foucar; Attilio Orazi; Courtney D. DiNardo; Srdan Verstovsek; Ramon V. Tiu; Adam Bagg; Eric D. Hsi; Daniel A. Arber; Francesco C. Stingo; Keyur P. Patel; Meenakshi Mehrotra; Ken H. Young; Elizabeth Weinzierl; Joseph Hatem; Jesse Jaso; Rashmi Kanagal-Shamanna; Sa A. Wang; Robert P. Hasserjian; Patricia S. Fox; Heesun J. Rogers; Julia T. Geyer

Archive | 2013

α chromosome-positive chronic myeloid leukemia after failure of interferon- Result of high-dose imatinib mesylate in patients with Philadelphia

Stefan Faderl; Srdan Verstovsek; Alessandra Ferrajoli; Emil J. Freireich; Moshe Talpaz; Hagop Jorge Cortes; Francis J. Giles; Susan O'Brien; Deborah A. Thomas; Guillermo Garcia-Manero; Mary Beth

Archive | 2013

chronic myeloid leukemia in accelerated or blast phase inhibitors is associated with a poor prognosis among patients with major cytogenetic response with second-generation tyrosine kinase Failure to achieve a complete hematologic response at the time of a

Jorge Cortes; Guillermo Garcia-Manero; Farhad Ravandi; Srdan Verstovsek; Gautam Borthakur; Jianqin Shan; Carmen Fava; Hagop M. Kantarjian; Elias Jabbour; Susan O'Brien; Nitin Jain; Mary Beth Rios

Archive | 2013

chronic lymphocytic leukemia Transient down-modulation of CD20 by rituximab in patients with

Sana Naeem; Srdan Verstovsek; Hagop Kantarjian; Francis J. Giles; Michael J. Keating; Susan O'Brien; Taghi Manshuri; Deborah A. Thomas; Vilmos Thomazy; Maha Imam

Archive | 2013

myeloid leukemia (AML) in patients 50 years of age or older Clofarabine and cytarabine combination as induction therapy for acute

William G. Wierda; Monica Kwari; Alessandra Ferrajoli; Zeev Estrov; Susan O'Brien; Charles Koller; Francis J. Giles; Stefan Faderl; Srdan Verstovsek; Jorge Cortes; Farhad Ravandi; Miloslav Beran

Explore More